Calquence Unione Europea - italiano - EMA (European Medicines Agency)

calquence

astrazeneca ab - acalabrutinib - leucemia, linfocitica, cronica, b-cell - antineoplastic agents, protein kinase inhibitors, - calquence as monotherapy or in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll). calquence as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (cll) who have received at least one prior therapy.

Calquence 100 mg Capsule rigide Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

calquence 100 mg capsule rigide

astrazeneca ag - acalabrutinibum - capsule rigide - acalabrutinibum 100 mg, cellulosum microcristallinum silicificatum, amylum pregelificatum, carboxymethylamylum natricum a corresp. natrium max. 0.25 mg, magnesii stearas, kapselhülle: gelatina, e 172 (flavum), e 132, e 171, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammonii hydroxidum, pro capsula. - chronisch lymphatische leukämie (cll) - synthetika

Tenkasi 400 mg Polvere per Concentrato per soluzione per Infusione Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

tenkasi 400 mg polvere per concentrato per soluzione per infusione

a. menarini gmbh - oritavancinum - polvere per concentrato per soluzione per infusione - praeparatio sicca: oritavancinum 400 mg ut oritavancini diphosphas, mannitolum, acidum phosphoricum q.s. ad ph pro vitro. - malattie infettive - synthetika

DABIKASTE Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

dabikaste

glenmark arzneimittel gmbh - dabigatran etexilato - dabigatran etexilato

Dabigatran Etexilate Accord Unione Europea - italiano - EMA (European Medicines Agency)

dabigatran etexilate accord

accord healthcare s.l.u. - dabigatran etexilate mesilato - venous thromboembolism; arthroplasty, replacement - agenti antitrombotici - prevention of venous thromboembolic events.

Calquence 100 mg Compresse rivestite con film Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

calquence 100 mg compresse rivestite con film

astrazeneca ag - acalabrutinibum - compresse rivestite con film - acalabrutinibum 100 mg ut acalabrutinibi maleas monohydricum, mannitolum, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, natrii stearylis fumaras, Überzug: hypromellosum, copovidonum, e 171, macrogolum 3350, triglycerida media, e 172 (flavum), e 172 (rubrum), pro compresso obducto corresp. natrium 0.59 mg. - chronisch lymphatische leukämie (cll) - synthetika